BCL2 and Huntington disease: Moreover, there was also a significant reduction of anti-apoptotic Bcl-2 protein level in both HD (34 ± 14%) and MS (50 ± 10%) lymphocytes exposed to 2-CdA (Figure 1A–C), and this reduction was more evident in MS lymphocytes (Figure 1C).